• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Studies on the generation and application of fusion protein of single chain antibody for P-glycoprotein and chemokine

Research Project

Project/Area Number 13557053
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field Respiratory organ internal medicine
Research InstitutionThe University of Tokushima

Principal Investigator

SONE Saburo  The University of Tokushima, School of Medicine, Professor, 医学部, 教授 (40145024)

Co-Investigator(Kenkyū-buntansha) YANO Seiji  The University of Tokushima, University Hospital, Assistant Professor, 医学部附属病院, 講師 (30294672)
NISHIOKA Yasuhiko  The University of Tokushima, School of Medicine, Assistant Professor, 医学部, 講師 (70274199)
TANI Kenji  The University of Tokushima, School of Medicine, Associate Professor, 医学部, 助教授 (70207166)
Project Period (FY) 2001 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥9,800,000 (Direct Cost: ¥9,800,000)
Fiscal Year 2002: ¥4,800,000 (Direct Cost: ¥4,800,000)
Fiscal Year 2001: ¥5,000,000 (Direct Cost: ¥5,000,000)
KeywordsMulti-drug resistance / P-glycoprotein / MRK16 / single chain antibody / P糖蛋白 / single chan抗体 / ケモカイン / 薬剤耐性 / 抗体治療 / 免疫療法 / MRK-16 / MCP-1
Research Abstract

The MDR1 gene product P-glycoprotein plays a key role in multidrug resistance of cancer cells. P-glycoprotein is the energy-dependent pump that extrudes a variety of chemotherapeutic drugs. Overexpression of P-glycoprotein results in multidrug resistance of tumor cell lines in vitro as well as in cancer patients. Therefore, much attention has been paid to P-glycoprotein as a molecular target for cancer treatment. MRK16 is the monoclonal antibody against P-glycoprotein and binds to an external domain of P-glycoprotein. It partially inhibits the efflux of certain chemotherapeutic drugs in multidrug-resistant cells, and leads the tumor regression in vivo. Due to the limitations of using intact murine antibodies in human clinical settings, we engineered a single-chain antibody fragment of MRK16 (scFvMRK16). After cloning the variable region of MRK16, both heavy and light chain fragments were fused with linker, and recombinant protein were produced from Escherichia coli. Although the binding activity of scFvMRK16 to P-glycoprotein was 200-300 fold less compared to MRK16, we confirmed by flow cytometric analysis that it does recognize the P-glycoprotein. Furthermore, scFvMRK16 could inhibit the activity of MRK16 to bind P-glycoprotein. These results indicated the therapeutic potential of scFvMRK16.

Report

(3 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • Research Products

    (38 results)

All Other

All Publications (38 results)

  • [Publications] Nishimura et al.: "Enhanced efficiency by centrifugal manipulation of adenovirus-mediated interleukin 12 gene transduction into human monocyte-derived dendritic cells"Hum Gene Ther. 12. 333-346 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Goto H et al.: "Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice"Cancer Res. 62. 3711-3715 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Shiraga M et al.: "Organ heterogeneity of host-derived metalloproteinase expression and its involvement in multiple-organ metastasis by lung cancer cell lines"Cancer Res.. 62. 5967-5973 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nishioka M et al.: "MYO18B, a candidate tumor suppressor gene at chromosome 22q12.1, deleted, mutated, and methylated in human lung cancer"P Natl Acad Sci USA. 99・19. 12269-12274 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yamamoto A et al.: "A Third-Generation Matrix Metalloproteinase (MMP) Inhibitor (ONO-4817) Combined with Docetaxel Suppresses Progression of Lung Micrometastasis of MMP-Expressing Tumor Cells in Nude Mice"Int J Cancer. 103. 822-828 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nishioka Y et al.: "Differential effects of IL-12 on the generation of alloreactive CTL mediated by murine and human dendritic cells : A critical role for nitric oxide"J Leukoc Biol. (In press). (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nishimura, N., Nishioka, Y., Shinohara, T. and Sone, S.: "Enhanced efficiency by centrifugal manipulation of adenovirus-mediated interleukin 12 gene transduction into human monocyte-derived dendritic cells."Hum. Gene Ther.. 12. 333-346 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Goto, H., Yano, S., Zhang, H., Matsumori, Y., Ogawa, H., David C. Blakey., and Sone, S.: "Activity of a New Vascular Targeting Agent, ZD6126, in Pulmonary Metastases by Human Lung Adenocarcinoma in Nude Mice"Cancer Res. 62. 3711-3715 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Shiraga, M., Yano, S., Yamamoto, A., Ogawa, H., Goto, H., Miki, T., Miki, K., Zhang, H. and Sone, S.: "Organ Heterogeneity of Host-derived Matrix Metalloproteinase Expression and Its Involvement in Multiple-Organ Metastasis by Lung Cancer Cell Lines"Cancer Res. 62. 5967-5973 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nishioka, M., Kohno, T., Tani, M., Yanaihara, N., Tomizawa, Y., Otsuka, A., Sasaki, S., Kobayashi, K., Niki, T., Maeshima, A., Sekido, Y., J.D.Minna., Sone, S. and Yokota, J.: "MYO18B, a candidate tumor suppressor gene at chromosome 22q12.1, deleted, mutated, and methylated in human lung cancer."PNAS. 99(19). 12269-12274 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yamamoto, A., Yano, S., Shiraga, M., Ogawa, H., Goto, H., Miki, T., Zhang, H. and Sone, S.: "A Third-Generation Matrix Metalloproteinase (MMP) Inhibitor (ONO-4817) Combined with Docetaxel Suppresses Progression of Lung Micrometastasis of MMP-Expressing Tumor Cells in Nude Mice"Int J Cancer. 103. 822-828 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nishioka Y, Wen H, Mitani K, Robbins PD, Lotze MT, Sone S and Tahara H.: "Differential effects of IL-12 on the generation of alloreactive CTL mediated by murine and human dendritic cells : A critical role for nitric oxide."J Leukoc Biol. (In press). (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Goto H et al.: "Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice"Cancer Res. 62. 3711-3715 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Shiraga M et al.: "Organ heterogeneity of host-derived metalloproteinase expression and its involvement in multiple-organ metastasis by lung cancer cell lines"Cancer Res.. 62. 5967-5973 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Nishioka M et al.: "MYO18B, a candidate tumor suppressor gene at chromosome 22q12.1, deleted, mutated, and methylated in human lung cancer"P Natl Acad Sci USA. 99・19. 12269-12274 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Yamamoto A et al.: "A Third-Generation Matrix Metalloproteinase (MMP) Inhibitor (ONO-4817) Combined with Docetaxel Suppresses Progression of Lung Micrometastasis of MMP-Expressing Tumor Cells in Nude Mice"Int J Cancer. 103. 822-828 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Nishioka Y et al.: "Differential effects of IL-12 on the generation of alloreactive CTL mediated by murine and human dendritic cells : A critical role for nitric oxide"J Leukoc Biol. (in press). (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Takeuchi, E. et al.: "IL-12-induced production of IL-10 and interferon-gamma by mononuclear cells in lung cancer-associated malignant pleural effusions"Lung Cancer. 35. 171-177 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Shinohara, T. et al.: "NF-kB-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53"Cancer Res.. 61. 673-678 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Shinohara, T. et al.: "Transduction of KAI1/CD82 cDNA promotes hematogenous spread of human lung-cancer cells in natural killer cell-depleted SCID mice"Int. J. Cancer. 94. 16-23 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Goto, H. et al.: "Gamma interferon-dependent induction of thymidine phosphorylase/platelet-derived endothelial growth factor through gamma-activated sequence-like element in human macrophages"Cancer Res.. 61. 469-473 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Nishimura, N. et al.: "Enhanced efficiency by centrifugal manupulation of adenovirus-mediated interleukin 12 gene transduction into human monocyte-derived dendritic cells"Hum. Gene Ther.. 12. 333-346 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Nishimura, N. et al.: "Novel centrifugal method for simple and highly efficient adenovirus-mediated green fluorescence protein gene transduction into human monocyte-deried dendritic cells"J. Immunological. Methods.. 253. 113-124 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Takeuchi, E. et al.: "Interleukin (IL-) 15 has less activity than IL-2 to promote type 2 cytokine predominance in tumour-associated mononuclear cells form lung cancer patients"Cytokine. 13. 119-123 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Parajuli, P. et al.: "Humanized anti-ganglioside GM2 antibody is effective to induce antibody-dependent cell-mediated cytotoxicity in mononuclear cells from lung cancer patients"Cancer Lett.. 163. 179-184 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Hanibuchi, M. et al.: "Immunological circumvention of multiple organ metastases of multidrug resistant human small cell lung cancer cells by mouse-human chimeric anti-ganglioside GM2 antibody KM966"Clin. Exp. Metastasis. 18. 353-360 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Cui, P.et al.: "A novel bioactive 31-amino acid endothelin-1 is a potent chemotactic peptide for human neutrophils and monocytes"J. Leukoc. Biol.. 70. 306-312 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Miki, T. et al.: "Bone metastasis model with multi-organ dissemination of human small cell lung cancer (SBC-5) cells in natural killer-cell depleted SCID mice"Oncol. Res.. 12. 209-217 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Tanaka, H. et al.: "CD40 and IFN-gamma dependent T cell activation by human bronchial epithelial cells"J. Med. Invest.. 48. 109-117 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Suzuki, Y. et al.: "Efficient generation of dendritic cells from alveolar and pleural macrophages as well as blood monocytes in patients with lung cancer"Lung Cancer. 34. 195-205 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Ge, N.et al.: "Interferon-gamma activates outwardly rectifying chloride channels in the human bronchial epithelial cell line BEAS-2B"J. Med. Invest.. 48. 97-101 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Sone, S. et al.: "Molecular pathogenesis of lung cancer and its molecular targeted therapy"Internal Med.. 40(2). 167-170 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Huang, L. et al.: "Thrombin promotes fibroblast proliferation during the early stages of experimental radiation pneumonitis"Radiation Res.. 156. 45-52 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Nokihara, H. et al.: "A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells"Jpn. J. Cancer Res.. 92. 785-792 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Ogushi, F. et al.: "Autoantibodies to IL-1α in sera from rapidly progressive idiopathic pulmonary fibrosis"J. Med. Invest.. 48. 181-189 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Tani, K. et al.: "Protease-induced leukocyte chemotaxis and activation : Roles in host defense and inflammation"J. Med. Invest.. 48. 133-141 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Hase, K. et al.: "Increased CCR4 expression in active systemic lupus erythematosus"J. Leukoc. Biol.. 70. 749-755 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Nishioka, Y. et al.: "Human monocyte-derived and CD83+ blood dendritic cells enhance NK cell-mediated cytotoxicity"Eur. J. Immunol.. 31. 2633-2641 (2001)

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi